Mylan And Pfizer Announce Key Date For Viatris Merger

Follows Delay Due To Coronavirus Pandemic

Mylan and Pfizer’s Upjohn have revealed a key date for their merger to create Viatris, after the deal set for midway through the year was pushed back recently due to the coronavirus pandemic.

MylanOffice
The latest move in Mylan and Upjohn's protracted bid to merge into Viatris has been disclosed • Source: Shutterstock

More from Deals

More from Business